Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Single-Payer Healthcare
  • Federal Workers’ Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

WHAT'S NEW

  • Single-Payer Healthcare
  • Federal Workers' Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Feb 20 2020

Full Issue

When Health Care Workers Misuse Opioids, Getting Them Help Poses Complicated Challenges

States can deny doctors access to medication approved to help them recover from opioid addiction, precisely because they practice medicine, according to a Boston Globe story. News on the epidemic is from Pennsylvania and Massachusetts, as well.

Boston Globe: Medical Community Struggles With Own Opioid Dilemma: How To Heal The Healers?

Medical professionals are far from immune to opioid misuse. In fact, due to their easy access to pain medication and the high stress levels that come with treating patients, they may be especially susceptible. But for many clinicians, overcoming an opioid dependence can be even more challenging than for those in the general population. (Eisner, 2/19)

Philadelphia Inquirer: A Montgomery County ‘Pill Mill’ Doctor Traded Cash For Opioids. Now He’s Heading To Federal Prison.

Spiro Y. Kassis, 66, was sentenced Wednesday to four years in prison after pleading guilty to illegally distributing controlled substances, including the opiate painkiller oxycodone. Separately, Kassis agreed to pay $1.4 million to settle a federal civil rights lawsuit and agreed to never again obtain a license for prescribing opioid medication. (Vella, 2/19)

The Boston Globe: Biotech Founder Who Said His Painkiller Would Replace Opioids Sentenced To 7 Years In Prison

The founder of a biotech who said his company had developed a painkiller that would replace morphine was sentenced to seven years in prison Tuesday for defrauding investors of $7.5 million. Frank Reynolds, the founder of PixarBio in Medford, Mass., and a former fellow at the MIT Sloan School of Management, held up a bottle of NeuroRelease in court and insisted that his never-approved drug still had value. (Stalzman, 2/19)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF